DGX

Quest Diagnostics Inc

DGX · CIK 1022079 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$11.0B
20182025
Net Income$1.0B
20182025
Operating CF$1.9B
20182025
Free Cash Flow$1.4B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$11.0B$9.9B$9.3B$9.9B$10.8B$3.0B$1.9B$1.8B
Cost of Revenue$7.4B$6.6B$6.2B$6.5B$6.6B$5.8B$5.0B$4.9B
Gross Profit$1.3B$0.7B$0.6B
R&D Expense
SG&A Expense$2.0B$1.8B$1.6B$1.9B$1.7B$1.6B$1.5B$1.4B
Operating Income$1.6B$1.3B$1.3B$1.4B$2.4B$2.0B$1.2B$1.1B
Net Income$1.0B$0.9B$0.9B$0.9B$2.0B$0.6B$0.3B$0.1B
EPS (Basic)$8.87$7.78$7.59$8.10$15.85$4.28$1.88$0.93
EPS (Diluted)$8.75$7.69$7.49$7.97$15.55$4.21$1.86$0.92

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$16.2B$16.2B$14.0B$12.8B$13.6B$14.0B$12.8B$11.0B
Current Assets$2.4B$2.4B$2.4B$1.9B$2.7B$3.1B$2.5B$1.4B
Cash & Equivalents$0.4B$0.5B$0.7B$0.3B$0.9B$1.2B$1.2B$0.1B
Total Liabilities
Current Liabilities$2.3B$2.2B$1.8B$1.6B$1.8B$1.8B$2.0B$1.5B
Stockholders' Equity$7.2B$6.8B$6.3B$5.9B$6.4B$6.8B$5.6B$5.2B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$1.9B$1.3B$1.3B$1.7B$2.2B$2.0B$1.2B$1.2B
Investing Cash Flow$-0.6B$-2.5B$-1.1B$-0.5B$0.0B$-0.8B$-0.4B$-0.8B
Capital Expenditures$0.5B$0.4B$0.4B$0.4B$0.4B$0.4B$0.4B$0.4B
Financing Cash Flow$-1.4B$1.1B$0.2B$-1.7B$-2.5B$-1.3B$0.2B$-0.4B